StockData
Tectonic Therapeutic, Inc. logo

Tectonic Therapeutic, Inc. (TECX) income statement

TECXNasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 5, 2026Score 7/30
$21.04+0.96 (+4.78%)

Close on Nov 18, 2026Market cap $411.32MP/E –Yield 0.00%

See a number that looks wrong?